Benzylamines

"Benzylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group.

Descriptor ID	D001596
MeSH Number(s)	D02.092.200 D02.455.426.559.389.140.210
Concept/Terms	Benzylamines Benzylamines alpha-Aminotoluene alpha-Aminotoluene alpha Aminotoluene Phenylmethylamine Phenylmethylamine

Below are MeSH descriptors whose meaning is more general than "Benzylamines".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amines [D02.092]
Benzylamines [D02.092.200]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Benzyl Compounds [D02.455.426.559.389.140]
Benzylamines [D02.455.426.559.389.140.210]

Below are MeSH descriptors whose meaning is related to "Benzylamines".

Below are MeSH descriptors whose meaning is more specific than "Benzylamines".

Benzylamines
Pargyline

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Benzylamines" by people in this website by year, and whether "Benzylamines" was a major or minor topic of these publications.

Bar chart showing 28 publications over 15 distinct years, with a maximum of 6 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	1	1
2004	0	3	3
2005	1	5	6
2006	2	1	3
2007	1	0	1
2008	0	2	2
2010	0	2	2
2011	1	0	1
2014	0	2	2
2016	1	0	1
2017	0	1	1
2018	0	2	2
2021	1	0	1
2024	0	1	1

Below are the most recent publications written about "Benzylamines" by people in Profiles.

Rader F, Oreziak A, Choudhury L, Saberi S, Fermin D, Wheeler MT, Abraham TP, Garcia-Pavia P, Zwas DR, Masri A, Owens A, Hegde SM, Seidler T, Fox S, Balaratnam G, Sehnert AJ, Olivotto I. Mavacamten Treatment for Symptomatic?Obstructive Hypertrophic?Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE?Cohort. JACC Heart Fail. 2024 01; 12(1):164-177.

View in: PubMed
Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 12 21; 78(25):2518-2532.

View in: PubMed
Hersh TA, Dimond AL, Ruth BA, Lupica NV, Bruce JC, Kelley JM, King BL, Lutton BV. A role for the CXCR4-CXCL12 axis in the little skate, Leucoraja erinacea. Am J Physiol Regul Integr Comp Physiol. 2018 08 01; 315(2):R218-R229.

View in: PubMed
Soni C, Schell SL, Fasnacht MJ, Chodisetti SB, Rahman ZS. Crucial role of Mer tyrosine kinase in the maintenance of SIGN-R1+ marginal zone macrophages. Immunol Cell Biol. 2018 03; 96(3):298-315.

View in: PubMed
Ross JA, Reyes BAS, Thomas SA, Van Bockstaele EJ. Localization of endogenous amyloid-? to the coeruleo-cortical pathway: consequences of noradrenergic depletion. Brain Struct Funct. 2018 Jan; 223(1):267-284.

View in: PubMed
Wohlfarth A, Roman M, Andersson M, Kugelberg FC, Diao X, Carlier J, Eriksson C, Wu X, Konradsson P, Josefsson M, Huestis MA, Kronstrand R. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal. 2017 May; 9(5):680-698.

View in: PubMed
He Q, Pu J, Yuan A, Lau WB, Gao E, Koch WJ, Ma XL, He B. Activation of liver-X-receptor a but not liver-X-receptor ? protects against myocardial ischemia/reperfusion injury. Circ Heart Fail. 2014 Nov; 7(6):1032-41.

View in: PubMed
Tolar J, McGrath JA. Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells. J Invest Dermatol. 2014 Sep; 134(9):2312-2314.

View in: PubMed
Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011; 11(1):1-11.

View in: PubMed
Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K. Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists. Blood. 2010 Dec 09; 116(24):5306-15.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement